A multidisciplinary team integrated clinical need, cancer biology, and microfluidic bioengineering to advance ...

Preclinical studies indicate that cavity-resident macrophages in the peritoneal and pleural spaces contribute to immunosuppression and cancer progression. While these macrophages typically accumulate ...

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung ...

In a study published in The Journal of Clinical Investigation, University of Michigan researchers found a new protein target ...

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States.Over 80% of lung ...

Immorta Bio today announced the publication of a landmark preclinical study in the Journal of Translational Medicine demonstrating that its novel immunotherapy, SenoVax(TM), dramatically reduces ...